Safety of administration of CUE-101, a novel HPV16 E7-pHLA-IL2-Fc fusion protein, before curative-intent treatment in patients with HPV16+ oropharyngeal squamous cell carcinoma.Sidharth V. Puram, Douglas R. Adkins, Patrik Pipkorn et al.|Journal of Clinical Oncology|2025Cited by 4
Abstract CT241: Phase 2 window of opportunity trial of pyrimethamine in locoregionally advanced head and neck squamous cell carcinomaPaul Zolkind, Michael B. Major, Emily Wilkerson et al.|Cancer Research|2026Cited by 0